QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.102.046219v1 305/3/909    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chaipatikul, V. Articles by Law, P. Y. Search for Related Content PubMed PubMed Citation Articles by Chaipatikul, V. Articles by Law, P. Y.

CELLULAR AND MOLECULAR

Ligand-Selective Activation of µ-Opioid Receptor: Demonstrated with Deletion and Single Amino Acid Mutations of Third Intracellular Loop Domain

Department of Pharmacology, Medical School, University of Minnesota, Minneapolis, Minnesota

The mechanism for the differential regulation of the µ-opioid receptor by agonists is investigated by identifying the receptor domains used to define the relative efficacies of three µ-opioid receptor-selective agonists: [D-Ala²,N-Me-Phe⁴,Gly⁵-ol]-enkephalin (DAMGO), morphine, and [N-MePhe³,D-Pro⁴]-morphiceptin (PL017) to inhibit forskolin-stimulated intracellular cAMP production in human embryonic kidney 293 cells. This was accomplished by systematically deleting four to five amino acids clusters within the third intracellular loop of rat µ-opioid receptor, Arg²⁵⁸ to Arg²⁸⁰, followed by Ala substitution and scanning studies of the ²⁷⁶RRITR²⁸⁰ sequence, the putative G protein-coupling motif. Deletion of the four to five amino acid clusters resulted in differential effects on the affinities of the agonists and antagonists, and also on the potencies and coupling efficiencies of the three opioid agonists. Ala scanning studies of the ²⁷⁶RRITR²⁸⁰ sequence revealed also the differences between [D-Ala²,N-Me-Phe⁴,Gly⁵-ol]-enkephalin (DAMGO), morphine, and PL017. Substitution of Arg²⁷⁶ or Ile²⁷⁸ with Ala reduced the potency of DAMGO but not that of morphine PL017. Meanwhile, mutation of Thr²⁷⁹ to Ala increased the potencies of morphine and PL017 but not that of DAMGO. The I278A mutation decreased the DAMGO coupling efficiency but increased the PL017 coupling efficiency. The R280A mutation resulted in the increase in PL017 potency and coupling efficiency without altering those of DAMGO and morphine. Thus, these mutation studies suggested that the activation of µ-opioid receptor and interaction between the critical domains such as RRITR within third intracellular loop and the G proteins are agonist-selective.

Address correspondence to: Dr. P. Y. Law, Department of Pharmacology, Medical School, University of Minnesota, 6-120 Jackson Hall, 321 Church St. S.E., Minneapolis, MN 55455-0217. E-mail: lawxx001{at}tc.umn.edu

This article has been cited by other articles:

				H. Zheng, J. Chu, Y. Qiu, H. H. Loh, and P.-Y. Law Agonist-selective signaling is determined by the receptor location within the membrane domains PNAS, July 8, 2008; 105(27): 9421 - 9426. [Abstract] [Full Text] [PDF]

				M. J. Clark, C. A. Furman, T. D. Gilson, and J. R. Traynor Comparison of the Relative Efficacy and Potency of {micro}-Opioid Agonists to Activate G{alpha}i/o Proteins Containing a Pertussis Toxin-Insensitive Mutation J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 858 - 864. [Abstract] [Full Text] [PDF]

				E. Morou and Z. Georgoussi Expression of the Third Intracellular Loop of the {delta}-Opioid Receptor Inhibits Signaling by Opioid Receptors and Other G Protein-Coupled Receptors J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1368 - 1379. [Abstract] [Full Text] [PDF]

				G. R. Kracke, K. A. Uthoff, and J. D. Tobias Sugar Solution Analgesia: The Effects of Glucose on Expressed Mu Opioid Receptors Anesth. Analg., July 1, 2005; 101(1): 64 - 68. [Abstract] [Full Text] [PDF]

				D. M. Perez and S. S. Karnik Multiple Signaling States of G-Protein-Coupled Receptors Pharmacol. Rev., June 1, 2005; 57(2): 147 - 161. [Abstract] [Full Text] [PDF]

				P.-Y. Law, L. J. Erickson-Herbrandson, Q. Q. Zha, J. Solberg, J. Chu, A. Sarre, and H. H. Loh Heterodimerization of {micro}- and {delta}-Opioid Receptors Occurs at the Cell Surface Only and Requires Receptor-G Protein Interactions J. Biol. Chem., March 25, 2005; 280(12): 11152 - 11164. [Abstract] [Full Text] [PDF]

				W. Wang, H. H. Loh, and P.-Y. Law The Intracellular Trafficking of Opioid Receptors Directed by Carboxyl Tail and a Di-leucine Motif in Neuro2A Cells J. Biol. Chem., September 19, 2003; 278(38): 36848 - 36858. [Abstract] [Full Text] [PDF]